Evaluation of Biomarkers of Traumatic Brain Injury (ALERT-TBI)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The primary objective of this study is to evaluate the utility of the Banyan UCH-L1/GFAP Detection Assay as an aid in the evaluation of suspected traumatic brain injury (Glasgow Coma Scale score 9-15) in conjunction with other clinical information within 12 hours of injury to assist in determining the need for a CT scan of the head.
Condition or disease
Traumatic Brain Injury
Other: Head CT scan and blood draw within 12 hours of injury
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subjects eligible for study participation will be over the age of 18 and present to the health care facility with a head injury at a time such that sample collection can be completed within 12 hours of injury. Subjects who will be permitted into the study include those who will meet all the inclusion criteria and will have none of the exclusion criteria.
subject is at least 18 years of age at screening
suspected traumatically induced head injury as a result of insult to the head from external force
GCS 9-15 at time of informed consent
workup includes head CT scan as part of clinical emergency care within 3 hours of presenting and within 12 hours of injury
blood sample collected within 3 hours of presenting and within 12 hours of injury
subject or legal representative is willing to undergo informed consent
participating in an interventional, therapeutic clinical study that may affect the results of this study (an observational study acceptable)
time of injury cannot be determined
primary diagnosis of ischemic or hemorrhagic stroke
venipuncture not feasible
a condition precluding entry into the CT scanner
subject has a neurodegenerative disease or other neurological disorder including dementia, Parkinson's disease, multiple sclerosis, seizure disorder, brain tumors, and history of neurosurgery, stroke or TIA within the last 30 days
administration of blood transfusion after head injury and prior to study blood draw
subject is otherwise determined by the Investigator to be unsuitable for participation